Clet Niyikiza

5.1k citations
29 papers · 3.8k indexed · 2 hit papers · h-index 15
Topics
Lung Cancer Treatments and Mutations (10 papers)Monoclonal and Polyclonal Antibodies Research (8 papers)HER2/EGFR in Cancer Research (7 papers)

In The Last Decade

Clet Niyikiza

29 papers receiving 3.7k citations

Hit Papers

Phase III Study of Pemetrexed in Combination With Cisplat...20002026200820172003200050010001.5k2.0k

Peers

Clet Niyikiza
Comparison fields: 5 of 93
  • Pulmonary and Respiratory Medicine 3.0k
  • Oncology 1.4k
  • Molecular Biology 585
  • Radiology, Nuclear Medicine and Imaging 356
  • Surgery 264
Replace Claude Denham with:
Claude Denham United States
Panos Fidias United States
Joseph Treat United States
J. Blatter Germany
Shuichi Hironaka Japan
Vincent Haddad United Kingdom
Salah‐Eddin Al‐Batran Germany
P. Lianes Spain
P. Murawa Poland
Vera Gorbounova Russia
Clet Niyikiza relative to Claude Denham United States Claude Denham's profile →
Citations per field
00.5×1.7×
Claude Denham · 1×
Citations per year

Countries citing papers authored by Clet Niyikiza

Since Specialization
Citations

This map shows the geographic impact of Clet Niyikiza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clet Niyikiza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clet Niyikiza more than expected).

Fields of papers citing papers by Clet Niyikiza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clet Niyikiza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clet Niyikiza. The network helps show where Clet Niyikiza may publish in the future.

Co-authorship network of co-authors of Clet Niyikiza

This figure shows the co-authorship network connecting the top 25 collaborators of Clet Niyikiza. A scholar is included among the top collaborators of Clet Niyikiza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clet Niyikiza. Clet Niyikiza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 18
2 1
3 93
4 1
5 2
6 3
7 14
8 1
9 5
10 4
11 4
12 33
13 74
14 57
15 34
16 31
17
Homocysteine and methylmalonic acid: markers to predict and avoid toxicity from pemetrexed therapy.
218
18 67
19 27
20
Phase III Trial of Gemcitabine Plus Cisplatin Versus Cisplatin Alone in Patients With Locally Advanced or Metastatic Non–Small-Cell Lung Cancerbreakdown →
606

About Clet Niyikiza

Clet Niyikiza is a scholar working on Oncology, Biomaterials and Otorhinolaryngology, having authored 29 papers that have together received 3.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (10 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and HER2/EGFR in Cancer Research (7 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (3.0k citations), Oncology (1.4k citations) and Biotechnology (195 citations). Clet Niyikiza has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Paolo Paoletti, U. Gatzemeier, Claude Denham, James J. Rusthoven, E. Kaukel, Salih Emri, Christian Manegold, Pierre Ruffiè, Michael Boyer and James T. Symanowski. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026